BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:ARS Pharmaceuticals\, Inc. (SPRY) investor events
X-WR-CALNAME:ARS Pharmaceuticals\, Inc. (SPRY) investor events
DESCRIPTION:Earnings calls and investor events for ARS Pharmaceuticals\, In
 c. (SPRY)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for ARS Pharmaceuticals\, I
 nc. (SPRY)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:e6d6db66-f7a4-4bef-9786-40582430c88d@equibles.com
DTSTAMP:20260611T040001Z
DTSTART;VALUE=DATE:20251110
DTEND;VALUE=DATE:20251111
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:ARS Pharmaceuticals\, Inc. (SPRY) Earnings Call\, FY2025 Q3
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/spry/calls/2025-q3
END:VEVENT
BEGIN:VEVENT
UID:9b91deb8-4aec-4d96-8657-8b66aae943a8@equibles.com
DTSTAMP:20260611T040003Z
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260310
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:ARS Pharmaceuticals\, Inc. (SPRY) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/spry/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:b3491049-9584-4f1c-9223-ef6d2d36582c@equibles.com
DTSTAMP:20260617T191046Z
DTSTART;VALUE=DATE:20260515
DTEND;VALUE=DATE:20260516
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:ARS Pharmaceuticals\, Inc. (SPRY) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/spry/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:f3212128-65db-4594-b297-8d25e795d8cb@equibles.com
DTSTAMP:20260813T034250Z
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260814
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:ARS Pharmaceuticals\, Inc. (SPRY) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://ir.ars
 -pharma.com/events/event-details/ars-pharmaceuticals-2q-2026-financial-res
 ults-conference-call
URL:https://equibles.com/stocks/spry/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:3fcdecc2-58d3-4848-9f37-c4585e3f8f44@equibles.com
DTSTAMP:20261004T120039Z
DTSTART:20260911T123500Z
DTEND:20260911T133500Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:ARS Pharmaceuticals\, Inc. (SPRY) Conference: Cantor Fitzgerald Hea
 lthcare Conference
DESCRIPTION:Cantor Fitzgerald Healthcare Conference\nWebcast: https://sqps.
 onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22
 &eventId=76336602&checkCompany=1&checkEmail=1&checkName=1
END:VEVENT
END:VCALENDAR
